Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

Merck and Moderna’s mRNA cancer vaccine is successful in efficacy trial

December 14, 2022 Research and Development

Merck & Co and Moderna have partnered to utilise the mRNA technology used to combat COVID-19, however this time the …
News

ClearPoint recruits first patient in laser therapy study to treat Glioblastoma

December 14, 2022 Research and Development

California, US-based ClearPoint Neuro has recruited the first patient in a clinical trial which will use ClearPoint’s Prism Neuro Laser …
News

AI model predicts CVD risk from single chest radiograph

December 14, 2022 Research and Development

A recently-developed AI model has been shown to predict ten-year incidences with a similar level of success to the current …
News

Autolus announces positive primary endpoint data in FELIX trial

December 13, 2022 Research and Development

Autolus Therapeutic, a clinical-stage biopharmaceutical company, has announced that the phase 2 FELIX clinical trial of obecabtagene autoleucel (obe-cel) in …
News

Seagen shares data for Adcetris combination for Hodgkin Lymphoma

December 13, 2022 Research and Development

Adcetris has long been one of Seagen’s top-selling and expanding products, and it has announced that the drug appeared successful …
News

New blood cancer treatment appears successful for most trial patients

December 12, 2022 Research and Development

A new and experimental immunotherapy treatment has appeared successful in treating patients with multiple myeloma in an ongoing phase 1/2 …
News

Positive results for BioVie’s Parkinson’s and Alzheimer’s phase 2 trials

December 6, 2022 Research and Development

BioVie has announced positive results from two phase 2 trials which have been assessing NE3107’s efficacy in treating Parkinson’s Disease …
News
national-cancer-institute-uurfmwa25f0-unsplash

Nkarta data supports natural killer cells in cancer treatment

December 6, 2022 Research and Development

San Francisco, US-based Nkarta have been assessing the power of natural killer (NK) cells in oncology treatments. The treatment is …
News

Innovent Biologics and UNION Therapeutics announce first dosing of Chinese subject in phase 1 study

December 5, 2022 Research and Development

Innovent Biologics, a biopharmaceutical company which develops, manufactures and commercialises medicines for the treatment of illnesses within the scope of …
News

Amgen’s obesity drug appears promising with few side effects

December 5, 2022 Research and Development

Amgen Inc’s new obesity drug has appeared promising in its small phase 1 trial, meaning they will be able to …
News

New insights into HIV vaccine revealed by researchers

December 5, 2022 Research and Development

Although researchers have previously always struggled to develop an efficient HIV vaccine, the results of a first-in-human clinical trial for …
News

GSK’s two new cancer drugs look promising

December 2, 2022 Research and Development

GlaxoSmithKline (GSK) appear to be making some positive progress in their oncology department, with drugs for both myelofibrosis and endometrial …
News

Elon Musk’s Neuralink to conduct human trials in 2023

December 1, 2022 Research and Development

Neuralink owner Elon Musk announced that he has submitted paperwork to the FDA which he hopes will allow Neuralink to …
News

Stem cell transplants could be offered to MS patients in new trial

November 30, 2022 Research and Development

In a world-first trial, the University of Sheffield and Sheffield Teaching Hospital NHS Foundation Trust will investigate the efficacy of …
News

Collaboration between BioNTech and Ryvu Therapeutics to develop and commercialise immuno-modulatory small molecule candidates

November 30, 2022 Research and Development

Ryvu Therapeutics, a clinical-stage oncology therapeutics development company, has announced a collaboration with BioNTech, which will consist of two parts: …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026